BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19147272)

  • 1. Editorial comment on: Observation should be considered as an alternative in management of renal masses in older and comorbid patients.
    Volpe A
    Eur Urol; 2009 Jun; 55(6):1428-9. PubMed ID: 19147272
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment on: Observation should be considered as an alternative in management of renal masses in older and comorbid patients.
    Remzi M
    Eur Urol; 2009 Jun; 55(6):1427-8. PubMed ID: 19147268
    [No Abstract]   [Full Text] [Related]  

  • 3. Observation should be considered as an alternative in management of renal masses in older and comorbid patients.
    Beisland C; Hjelle KM; Reisaeter LA; Bostad L
    Eur Urol; 2009 Jun; 55(6):1419-27. PubMed ID: 19147267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial comment on: Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma.
    Novara G
    Eur Urol; 2009 May; 55(5):1153-4. PubMed ID: 18930580
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
    Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
    J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active surveillance of renal masses in elderly patients.
    Abouassaly R; Lane BR; Novick AC
    J Urol; 2008 Aug; 180(2):505-8; discussion 508-9. PubMed ID: 18550113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal cell carcinoma: urologists in a new era.
    Uzzo RG
    J Urol; 2005 Nov; 174(5):1723-4. PubMed ID: 16217270
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment on: Collecting duct renal cell carcinoma: a matched analysis of 41 cases.
    Pantuck AJ
    Eur Urol; 2007 Oct; 52(4):1145-6. PubMed ID: 17336450
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial comment on: Collecting duct renal cell carcinoma: a matched analysis of 41 cases.
    van der Kwast TH
    Eur Urol; 2007 Oct; 52(4):1146. PubMed ID: 17336448
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial comment on: impact of gender in renal cell carcinoma: an analysis of the SEER database.
    Murai M
    Eur Urol; 2008 Jul; 54(1):140-1. PubMed ID: 18160208
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial comment on: impact of gender in renal cell carcinoma: an analysis of the SEER database.
    Patard JJ
    Eur Urol; 2008 Jul; 54(1):141-2. PubMed ID: 18160206
    [No Abstract]   [Full Text] [Related]  

  • 12. The natural history of small renal masses.
    Volpe A; Jewett MA
    Nat Clin Pract Urol; 2005 Aug; 2(8):384-90. PubMed ID: 16474735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial comment on: Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Kirkali Z
    Eur Urol; 2009 Feb; 55(2):460. PubMed ID: 18692949
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment on: Vaccine therapy in patients with renal cell carcinoma.
    Bellmunt J; Ribas A
    Eur Urol; 2009 Jun; 55(6):1342-3. PubMed ID: 19201525
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic factors in renal cell cancer.
    Park WH; Eisen T
    BJU Int; 2007 May; 99(5 Pt B):1277-81. PubMed ID: 17441924
    [No Abstract]   [Full Text] [Related]  

  • 16. Kidney cancer in the elderly.
    Kirkali Z
    Urol Oncol; 2009; 27(6):673-6. PubMed ID: 19879478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of comorbidity in competing risks analysis in patients with localized renal cell carcinoma.
    Lagro J; Melis RJ; Olde Rikkert MG
    J Clin Oncol; 2010 Jun; 28(18):e298; author reply e301. PubMed ID: 20479414
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of adjuvant interferon-alpha therapy following curative resection in renal cell carcinoma: before the molecular targeting therapy era.
    Kai F; Takayama T; Sugiyama T; Furuse H; Mugiya S; Ozono S
    Jpn J Clin Oncol; 2009 May; 39(5):310-4. PubMed ID: 19363055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial comment.
    Russo P
    Urology; 2009 May; 73(5):1082. PubMed ID: 19394510
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial Comment on: Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
    Staehler M
    Eur Urol; 2007 Oct; 52(4):1155. PubMed ID: 17287072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.